NRC Health

Hello, everyone, and welcome to the National Research Corporation's first quarter 2023 earnings call. My name is Daisy, and I'll be coordinating your call today. If you would like to register a question, please press star followed by one on your telephone keypad. And I would now like to hand over to your co-host, Kevin Karras, the company's chief financial officer, to begin. So, Kevin, please go ahead.

Thank you, Daisy. and welcome everyone to National Research Corporation's 2023 First Quarter Earnings Call. My name is Kevin Karras, the company's CFO, and joining me on the call today is Linda Stacey, our Vice President of Finance. Before we continue, I'd like to ask Linda to review conditions related to any forward-looking statements that may be made as a part of today's call.

Thank you, Kevin. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Securities and Exchange Commission. With that, I'll turn it back to you, Kevin.